US Stock MarketDetailed Quotes

NRSN NeuroSense Therapeutics

Watchlist
  • 1.230
  • -0.030-2.38%
Close Apr 26 16:00 ET
  • 1.280
  • +0.050+4.07%
Post 19:56 ET
22.86MMarket Cap-1481P/E (TTM)

NeuroSense Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NeuroSense Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.16

+40.74%
Analyst Rating

No Data

NeuroSense Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

NeuroSense Therapeutics Earnings Reports

  • NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 12 16:33 ET

  • NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 5 09:33 ET

  • NeuroSense Therapeutics | 20-F: Registration statement / Annual report / Transition report

    Apr 4 16:37 ET

  • NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 28, 2023 09:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg